Relative bioavailability of topiramate administered rectally

Author： Conway J.M. Birnbaum A.K. Kriel R.L. Cloyd J.C.

Publisher： Elsevier

ISSN： 0920-1211

Source： Epilepsy Research, Vol.54, Iss.2, 2003-05, pp. : 91-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers

By Dutta S. Zhang Y. Selness D.S. Lee L.L. Williams L.A. Sommerville K.W.

Epilepsy Research, Vol. 49, Iss. 1, 2002-03 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite

Topiramate in migraine prophylaxis

By Diener Hans-Christoph Tfelt-Hansen P. Dahlöf C. Láinez M. Sandrini G. Wang Sh.-J. Neto W. Vijapurkar U. Doyle A. Jacobs D.

Journal of Neurology, Vol. 251, Iss. 8, 2004-08 ,pp. : 943-950

Springer Publishing Company

Access to resources Recommend Favorite

Effect of topiramate on attention

By Burton L.A. Harden C.

Epilepsy Research, Vol. 27, Iss. 1, 1997-04 ,pp. : 29-32

Elsevier

Access to resources Recommend Favorite

Topiramate in migraine prophylaxis

By Láinez Miguel JA

Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. : 357-364

Future Medicine

Access to resources Recommend Favorite

Chronic migraine prevention with topiramate

By Peres M. Mercante J. Tanuri F. Nunes M. Zukerman E.

The Journal of Headache and Pain, Vol. 7, Iss. 4, 2006-09 ,pp. : 185-187

Springer Publishing Company

Access to resources Recommend Favorite